Background: The psychotomimetics ketamine and MK-801, non-competitive NMDA receptor (NMDAr) antagonists, induce cognitive impairment and aggravate schizophrenia symptoms. In conscious rats, they produce an abnormal behavior associated with a peculiar brain state characterized by increased synchronization in ongoing c (30–80 Hz) oscillations in the frontoparietal (sensorimotor) electrocorticogram (ECoG). This study investigated whether NMDAr antagonists-induced aberrant c oscillations are correlated with locomotion and dependent on hyperlocomotion-related sensorimotor processing. This also implied to explore the contribution of intracortical and subcortical networks in the generation of these pathophysiological ECoG c oscillations. Methodolo...
Item does not contain fulltextThe non-competitive N-methyl d-aspartate glutamate receptor (NMDAR) an...
Antagonists of N-methyl-D-aspartate receptors (NMDAR) have psychotomimetic effects in humans and are...
doi: 0.3389/conf.fncom.2011.53.00186 Conference: BC11 : Computational Neuroscience & Neurotechnology...
The psychotomimetics ketamine and MK-801, non-competitive NMDA receptor (NMDAr) antagonists, induce ...
International audienceNMDAr antagonists acutely produces, in the rodent CNS, generalized aberrant ga...
International audienceBACKGROUND: Single subanesthetic doses of ketamine, a non-competitive NMDA rec...
Acute administration of NMDA receptor antagonists such as PCP and ketamine are accepted models of sc...
ABSTRACT BACKGROUND: Disconnections in cortical-related networks, the neuronal circuits of higher-o...
© 2017 Dr. Jaime LeeCognitive deficits in schizophrenia represent the most disabling symptom categor...
© 2019 Elysia Maree SokolenkoSchizophrenia is a chronic, heterogeneous psychiatric disorder characte...
International audienceA single non-anaesthetic dose of ketamine, a non-competitive NMDA receptor (NM...
International audienceIn prodromal and early schizophrenia, disorders of attention and perception ar...
Alterations in the function of the medial prefrontal cortex (mPFC) and its major thalamic source of ...
Alterations in the function of the medial prefrontal cortex (mPFC) and its major thalamic source of ...
Sherpa Romeo green journal; open accessAntagonists of N-methyl-D-aspartate receptors (NMDAR) have ps...
Item does not contain fulltextThe non-competitive N-methyl d-aspartate glutamate receptor (NMDAR) an...
Antagonists of N-methyl-D-aspartate receptors (NMDAR) have psychotomimetic effects in humans and are...
doi: 0.3389/conf.fncom.2011.53.00186 Conference: BC11 : Computational Neuroscience & Neurotechnology...
The psychotomimetics ketamine and MK-801, non-competitive NMDA receptor (NMDAr) antagonists, induce ...
International audienceNMDAr antagonists acutely produces, in the rodent CNS, generalized aberrant ga...
International audienceBACKGROUND: Single subanesthetic doses of ketamine, a non-competitive NMDA rec...
Acute administration of NMDA receptor antagonists such as PCP and ketamine are accepted models of sc...
ABSTRACT BACKGROUND: Disconnections in cortical-related networks, the neuronal circuits of higher-o...
© 2017 Dr. Jaime LeeCognitive deficits in schizophrenia represent the most disabling symptom categor...
© 2019 Elysia Maree SokolenkoSchizophrenia is a chronic, heterogeneous psychiatric disorder characte...
International audienceA single non-anaesthetic dose of ketamine, a non-competitive NMDA receptor (NM...
International audienceIn prodromal and early schizophrenia, disorders of attention and perception ar...
Alterations in the function of the medial prefrontal cortex (mPFC) and its major thalamic source of ...
Alterations in the function of the medial prefrontal cortex (mPFC) and its major thalamic source of ...
Sherpa Romeo green journal; open accessAntagonists of N-methyl-D-aspartate receptors (NMDAR) have ps...
Item does not contain fulltextThe non-competitive N-methyl d-aspartate glutamate receptor (NMDAR) an...
Antagonists of N-methyl-D-aspartate receptors (NMDAR) have psychotomimetic effects in humans and are...
doi: 0.3389/conf.fncom.2011.53.00186 Conference: BC11 : Computational Neuroscience & Neurotechnology...